BNP Paribas Financial Markets
STLN

BNP Paribas Financial Markets’s Starling Oncology STLN Stock Holding History

BNP Paribas Financial Markets’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$117K Buy
21,461
+4,533
+27% +$19K ﹤0.01% 4473
2026
Q1 		$52K Buy
16,928
+1,950
+13% +$5.98K ﹤0.01% 4675
2025
Q4 		$53.3K Buy
14,978
+2,859
+24% +$10.6K ﹤0.01% 4661
2025
Q3 		$42.3K Buy
12,119
+7,091
+141% +$24.3K ﹤0.01% 4668
2025
Q2 		$10.3K Buy
5,028
+5,023
+100,460% +$12.6K ﹤0.01% 4835
2025
Q1 		$6 Hold
5
– – ﹤0.01% 5352
2024
Q4 		$2 Buy
+5
New +$1 ﹤0.01% 5390

Other funds holding STLN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $159M AUM 142.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BNP Paribas Financial Markets's STLN Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Starling Oncology (STLN) stake by 27% in Q2 2026, buying an estimated $19K and bringing the position to 21,461 shares worth $117K. The position accounts for ﹤0.01% of the portfolio, ranked #4473.

BNP Paribas Financial Markets first reported a position in STLN in Q4 2024 and has held it in 7 quarters since. 119 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • BNP Paribas Financial Markets held 21,461 shares of Starling Oncology worth $117K as of Q2 2026.
  • BNP Paribas Financial Markets bought 4,533 Starling Oncology shares in Q2 2026, an estimated $19K.
  • Starling Oncology made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4473 holding.
  • BNP Paribas Financial Markets first reported a position in Starling Oncology in Q4 2024 and has held it in 7 quarters since.
  • 119 funds tracked by Wall St. Rank held Starling Oncology as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.